Cargando…
Comparative Effectiveness and Safety of Oral P2Y12 Inhibitors in Patients on Chronic Dialysis
INTRODUCTION: Although oral P2Y(12) inhibitors (P2Y12-Is) are one of the most commonly prescribed medication classes in patients with end stage kidney disease on dialysis (ESKD), scarce data exist regarding their benefits and risks. METHODS: We compared effectiveness and safety of clopidogrel, prasu...
Autores principales: | Jain, Nishank, Phadnis, Milind A., Hunt, Suzanne L., Dai, Junqiang, Shireman, Theresa I., Davis, Clayton L., Mehta, Jawahar L., Rasu, Rafia S., Hedayati, S. Susan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8418979/ https://www.ncbi.nlm.nih.gov/pubmed/34514199 http://dx.doi.org/10.1016/j.ekir.2021.06.031 |
Ejemplares similares
-
Trends for and Clinical Factors Associated with Choice of Oral P2Y(12) Inhibitors for Patients on Chronic Dialysis
por: Jain, Nishank, et al.
Publicado: (2019) -
Shorter length of hospital stay for hip fracture in those with dementia and without a known diagnosis of osteoporosis in the USA
por: Rasu, Rafia S., et al.
Publicado: (2020) -
Effectiveness comparison of cardio-selective to non-selective β-blockers and their association with mortality and morbidity in end-stage renal disease: a retrospective cohort study
por: Shireman, Theresa I., et al.
Publicado: (2016) -
Association of platelet function with depression and its treatment with sertraline in patients with chronic kidney disease: analysis of a randomized trial
por: Jain, Nishank, et al.
Publicado: (2019) -
Effect Modification of Chronic Kidney Disease on the Association of Circulating and Imaging Cardiac Biomarkers With Outcomes
por: Gregg, L. Parker, et al.
Publicado: (2017)